Apollo Awaits First Proof-Of-Concept Data For Atopic Dermatitis Drug

 
• By Andrew McConaghie
  
Apollo Therapeutics is working with leading UK universities to translate research into novel drugs, but is also in-licensing biopharma assets. (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Start-Ups & SMEs

More from Alimentary/Metabolic